• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Diagnostics Pipeline: Xella Health Launches Platform Focused on Women’s Medical Issues

Diagnostics Pipeline: Xella Health Launches Platform Focused on Women’s Medical Issues

by Ron Shinkman | Jul 20, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet, Point of Care-dtet

The startup is trying to close the care gap between female and male patients

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Growing Need for Companion Diagnostics is Evident at Drug Discovery Event

Growing Need for Companion Diagnostics is Evident at Drug Discovery Event

by Scott Wallask | Jun 30, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

The momentum for targeted therapies has downstream implications for clinical laboratories

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope

Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope

by Ron Shinkman | May 24, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet

New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety

Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety

by Ron Shinkman | May 13, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet

Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge

GRAIL’s Moves with MCED Test Illustrate Direct-to-Consumer Surge

by G2 Intelligence Staff | May 13, 2026 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com